Status:
COMPLETED
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery
Lead Sponsor:
Fudan University
Conditions:
Mammary Cancer
PONV
Eligibility:
FEMALE
18-64 years
Phase:
NA
Brief Summary
Breast cancer is one of the three most common cancers worldwide, and the primary treatment method is surgery.Since most patients are non-smokers who use opioids in the postoperative period, which are ...
Detailed Description
186 patients who are planed to undergo elective breast cancer surgery under general anaesthesia into the following three groups: acupoint stimulation+dexamethasone (Group Acu, n=62), granisetron +dexa...
Eligibility Criteria
Inclusion
- women undergoing breast cancer resection under general anesthesia
- aged between 18 to 65
- American Society of Anesthesiologists grade I-II
Exclusion
- using antiemetic drugs within 24 h before operation,
- nausea or vomiting within 24 h before operation;
- Alcoholic or drug abuse,
- abnormal liver and/or kidney function, diabetic or peripheral neuropathy patients, cardiovascular disease (excluding those with controlled hypertension).
- refuse to participate clinical trial
Key Trial Info
Start Date :
June 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2023
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT05408676
Start Date
June 10 2022
End Date
May 2 2023
Last Update
September 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032